68Ga-PSMA-617 PET/CT

DRUG2 trials

Sponsors

University Hospital, Bordeaux

Conditions

Prostate Cancer

Phase 2

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

CompletedNCT03604757

University Hospital, BordeauxProstate Cancer

Start: 2018-04-25End: 2019-12-19Updated: 2026-05-14

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging

CompletedNCT03606837

University Hospital, BordeauxProstate Cancer

Start: 2019-07-11End: 2023-07-11Updated: 2026-07-30